Both compounds have gained attention in precision weight management, but combining them requires careful clinical evaluation and individualized dosing strategy
JAMA Netw Open 7(8):e2423385 Zhou J, Huang W, Xie Y, Shen H, Liu M, Wu X (2025) Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database
Cc vn lo ha ca da s xut hin nh np nhn, nm, sm, tn nhang, Vi vic b sung cc dng cht gip chm sc da, chng lo ha v ci thin lo ha, ngi b mn kinh hon ton c th s dng c vin ung ci thin cc vn v da do tui tc
The agency also issued multiple waves of warning letters (dozens in total) to telehealth companies, citing false or misleading claims that suggested compounded products were equivalent to FDA-approved drugs in safety, efficacy, or quality.